Global Red Biotechnology Market 2025-2029

Publisher TechNavio

Published Aug 14, 2025

Length 215 Pages

SKU # INF20329149

Description

Red Biotechnology Market 2025-2029

The red biotechnology market is forecasted to grow by USD 254.3 bn during 2024-2029, accelerating at a CAGR of 7% during the forecast period. The report on the red biotechnology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in genomic research, increase in prevalence of chronic diseases, and growing aging population globally.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's red biotechnology market is segmented as below:

By Product

Monoclonal antibodies
Gene therapy
Polyclonal antibodies
Cell-based immunotherapy products
Others

By End-user

Pharmaceutical and biotechnology companies
CMOs and CROs
Academic research institutes

By Diagnostic Methods

Molecular diagnostics
Immunoassays
NGS

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rising STEM cell research and therapies as one of the prime reasons driving the red biotechnology market growth during the next few years. Also, increasing production of biopharmaceuticals and therapeutic proteins and rising prevalence of bioinformatics and data analytics will lead to sizable demand in the market.

The report on the red biotechnology market covers the following areas:

Red Biotechnology Market sizing
Red Biotechnology Market forecast
Red Biotechnology Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading red biotechnology market vendors that include Amgen Inc., Astellas Pharma Inc., AstraZeneca PLC, Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., CRISPR Therapeutics AG, Editas Medicine Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Merck KGaA, Mesoblast Ltd., Moderna Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., STEMCELL Technologies Inc., and Teva Pharmaceutical Industries Ltd.. Also, the red biotechnology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Market Segmentation by Diagnostic Methods; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ billion); Data Table on Global - Market size and forecast 2024-2029 ($ billion); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Red Biotechnology Market 2019 - 2023; Historic Market Size - Data Table on Global Red Biotechnology Market 2019 - 2023 ($ billion); 5.2 Product segment analysis 2019 - 2023; Historic Market Size - Product Segment 2019 - 2023 ($ billion); 5.3 End-user segment analysis 2019 - 2023; Historic Market Size - End-user Segment 2019 - 2023 ($ billion); 5.4 Diagnostic Methods segment analysis 2019 - 2023; Historic Market Size - Diagnostic Methods Segment 2019 - 2023 ($ billion); 5.5 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ billion); 5.6 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis: 6.1 Impact of AI in the global red biotechnology market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product: 8.1 Market segments; Chart on Product - Market share 2024-2029 (%); Data Table on Product - Market share 2024-2029 (%); 8.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 8.3 Monoclonal antibodies - Market size and forecast 2024-2029; Chart on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion); Data Table on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion); Chart on Monoclonal antibodies - Year-over-year growth 2024-2029 (%); Data Table on Monoclonal antibodies - Year-over-year growth 2024-2029 (%); 8.4 Gene therapy - Market size and forecast 2024-2029; Chart on Gene therapy - Market size and forecast 2024-2029 ($ billion); Data Table on Gene therapy - Market size and forecast 2024-2029 ($ billion); Chart on Gene therapy - Year-over-year growth 2024-2029 (%); Data Table on Gene therapy - Year-over-year growth 2024-2029 (%); 8.5 Polyclonal antibodies - Market size and forecast 2024-2029; Chart on Polyclonal antibodies - Market size and forecast 2024-2029 ($ billion); Data Table on Polyclonal antibodies - Market size and forecast 2024-2029 ($ billion); Chart on Polyclonal antibodies - Year-over-year growth 2024-2029 (%); Data Table on Polyclonal antibodies - Year-over-year growth 2024-2029 (%); 8.6 Cell-based immunotherapy products - Market size and forecast 2024-2029; Chart on Cell-based immunotherapy products - Market size and forecast 2024-2029 ($ billion); Data Table on Cell-based immunotherapy products - Market size and forecast 2024-2029 ($ billion); Chart on Cell-based immunotherapy products - Year-over-year growth 2024-2029 (%); Data Table on Cell-based immunotherapy products - Year-over-year growth 2024-2029 (%); 8.7 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ billion); Data Table on Others - Market size and forecast 2024-2029 ($ billion); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 8.8 Market opportunity by Product; Market opportunity by Product ($ billion); Data Table on Market opportunity by Product ($ billion)
9 Market Segmentation by End-user: 9.1 Market segments; Chart on End-user - Market share 2024-2029 (%); Data Table on End-user - Market share 2024-2029 (%); 9.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 9.3 Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029; Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ billion); Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ billion); Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%); Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%); 9.4 CMOs and CROs - Market size and forecast 2024-2029; Chart on CMOs and CROs - Market size and forecast 2024-2029 ($ billion); Data Table on CMOs and CROs - Market size and forecast 2024-2029 ($ billion); Chart on CMOs and CROs - Year-over-year growth 2024-2029 (%); Data Table on CMOs and CROs - Year-over-year growth 2024-2029 (%); 9.5 Academic research institutes - Market size and forecast 2024-2029; Chart on Academic research institutes - Market size and forecast 2024-2029 ($ billion); Data Table on Academic research institutes - Market size and forecast 2024-2029 ($ billion); Chart on Academic research institutes - Year-over-year growth 2024-2029 (%); Data Table on Academic research institutes - Year-over-year growth 2024-2029 (%); 9.6 Market opportunity by End-user; Market opportunity by End-user ($ billion); Data Table on Market opportunity by End-user ($ billion)
10 Market Segmentation by Diagnostic Methods: 10.1 Market segments; Chart on Diagnostic Methods - Market share 2024-2029 (%); Data Table on Diagnostic Methods - Market share 2024-2029 (%); 10.2 Comparison by Diagnostic Methods; Chart on Comparison by Diagnostic Methods; Data Table on Comparison by Diagnostic Methods; 10.3 Molecular diagnostics - Market size and forecast 2024-2029; Chart on Molecular diagnostics - Market size and forecast 2024-2029 ($ billion); Data Table on Molecular diagnostics - Market size and forecast 2024-2029 ($ billion); Chart on Molecular diagnostics - Year-over-year growth 2024-2029 (%); Data Table on Molecular diagnostics - Year-over-year growth 2024-2029 (%); 10.4 Immunoassays - Market size and forecast 2024-2029; Chart on Immunoassays - Market size and forecast 2024-2029 ($ billion); Data Table on Immunoassays - Market size and forecast 2024-2029 ($ billion); Chart on Immunoassays - Year-over-year growth 2024-2029 (%); Data Table on Immunoassays - Year-over-year growth 2024-2029 (%); 10.5 NGS - Market size and forecast 2024-2029; Chart on NGS - Market size and forecast 2024-2029 ($ billion); Data Table on NGS - Market size and forecast 2024-2029 ($ billion); Chart on NGS - Year-over-year growth 2024-2029 (%); Data Table on NGS - Year-over-year growth 2024-2029 (%); 10.6 Market opportunity by Diagnostic Methods; Market opportunity by Diagnostic Methods ($ billion); Data Table on Market opportunity by Diagnostic Methods ($ billion)
11 Customer Landscape: 11.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape: 12.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 12.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 12.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ billion); Data Table on North America - Market size and forecast 2024-2029 ($ billion); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 12.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ billion); Data Table on Europe - Market size and forecast 2024-2029 ($ billion); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 12.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ billion); Data Table on Asia - Market size and forecast 2024-2029 ($ billion); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 12.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 12.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ billion); Data Table on US - Market size and forecast 2024-2029 ($ billion); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 12.8 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ billion); Data Table on Germany - Market size and forecast 2024-2029 ($ billion); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 12.9 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ billion); Data Table on China - Market size and forecast 2024-2029 ($ billion); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 12.10 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ billion); Data Table on Canada - Market size and forecast 2024-2029 ($ billion); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 12.11 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ billion); Data Table on UK - Market size and forecast 2024-2029 ($ billion); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 12.12 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ billion); Data Table on India - Market size and forecast 2024-2029 ($ billion); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 12.13 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ billion); Data Table on France - Market size and forecast 2024-2029 ($ billion); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 12.14 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ billion); Data Table on Japan - Market size and forecast 2024-2029 ($ billion); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 12.15 Italy - Market size and forecast 2024-2029; Chart on Italy - Market size and forecast 2024-2029 ($ billion); Data Table on Italy - Market size and forecast 2024-2029 ($ billion); Chart on Italy - Year-over-year growth 2024-2029 (%); Data Table on Italy - Year-over-year growth 2024-2029 (%); 12.16 South Korea - Market size and forecast 2024-2029; Chart on South Korea - Market size and forecast 2024-2029 ($ billion); Data Table on South Korea - Market size and forecast 2024-2029 ($ billion); Chart on South Korea - Year-over-year growth 2024-2029 (%); Data Table on South Korea - Year-over-year growth 2024-2029 (%); 12.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ billion); Data Tables on Market opportunity By Geographical Landscape ($ billion)
13 Drivers, Challenges, and Opportunity/Restraints: 13.1 Market drivers; 13.2 Market challenges; 13.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 13.4 Market opportunities/restraints
14 Competitive Landscape: 14.1 Overview; 14.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 14.3 Landscape disruption; Overview on factors of disruption; 14.4 Industry risks; Impact of key risks on business
15 Competitive Analysis: 15.1 Companies profiled; Companies covered; 15.2 Company ranking index; Company ranking index; 15.3 Market positioning of companies; Matrix on companies position and classification; 15.4 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; SWOT; 15.5 Astellas Pharma Inc.; Astellas Pharma Inc. - Overview; Astellas Pharma Inc. - Product / Service; Astellas Pharma Inc. - Key offerings; SWOT; 15.6 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; SWOT; 15.7 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; SWOT; 15.8 Biogen Inc.; Biogen Inc. - Overview; Biogen Inc. - Product / Service; Biogen Inc. - Key offerings; SWOT; 15.9 Boehringer Ingelheim International GmbH; Boehringer Ingelheim International GmbH - Overview; Boehringer Ingelheim International GmbH - Product / Service; Boehringer Ingelheim International GmbH - Key news; Boehringer Ingelheim International GmbH - Key offerings; SWOT; 15.10 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; SWOT; 15.11 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; SWOT; 15.12 Gilead Sciences Inc.; Gilead Sciences Inc. - Overview; Gilead Sciences Inc. - Product / Service; Gilead Sciences Inc. - Key news; Gilead Sciences Inc. - Key offerings; SWOT; 15.13 Merck KGaA; Merck KGaA - Overview; Merck KGaA - Business segments; Merck KGaA - Key news; Merck KGaA - Key offerings; Merck KGaA - Segment focus; SWOT; 15.14 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; SWOT; 15.15 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 15.16 Regeneron Pharmaceuticals Inc.; Regeneron Pharmaceuticals Inc. - Overview; Regeneron Pharmaceuticals Inc. - Product / Service; Regeneron Pharmaceuticals Inc. - Key offerings; SWOT; 15.17 STEMCELL Technologies Inc.; STEMCELL Technologies Inc. - Overview; STEMCELL Technologies Inc. - Product / Service; STEMCELL Technologies Inc. - Key offerings; SWOT; 15.18 Teva Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd. - Overview; Teva Pharmaceutical Industries Ltd. - Business segments; Teva Pharmaceutical Industries Ltd. - Key news; Teva Pharmaceutical Industries Ltd. - Key offerings; Teva Pharmaceutical Industries Ltd. - Segment focus; SWOT
16 Appendix: 16.1 Scope of the report; 16.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 16.3 Currency conversion rates for US$; Currency conversion rates for US$; 16.4 Research methodology; Research methodology; 16.5 Data procurement; Information sources; 16.6 Data validation; Data validation; 16.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 16.8 Data synthesis; Data synthesis; 16.9 360 degree market analysis; 360 degree market analysis; 16.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by End-user; Exhibits7: Executive Summary - Chart on Market Segmentation by Diagnostic Methods; Exhibits8: Executive Summary - Chart on Incremental Growth; Exhibits9: Executive Summary - Data Table on Incremental Growth; Exhibits10: Executive Summary - Chart on Company Market Positioning; Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits12: Overview on criticality of inputs and factors of differentiation; Exhibits13: Overview on factors of disruption; Exhibits14: Impact of drivers and challenges in 2024 and 2029; Exhibits15: Parent Market; Exhibits16: Data Table on - Parent Market; Exhibits17: Market characteristics analysis; Exhibits18: Value chain analysis; Exhibits19: Offerings of companies included in the market definition; Exhibits20: Market segments; Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ billion); Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ billion); Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits25: Historic Market Size - Data Table on Global Red Biotechnology Market 2019 - 2023 ($ billion); Exhibits26: Historic Market Size - Product Segment 2019 - 2023 ($ billion); Exhibits27: Historic Market Size - End-user Segment 2019 - 2023 ($ billion); Exhibits28: Historic Market Size - Diagnostic Methods Segment 2019 - 2023 ($ billion); Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ billion); Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ billion); Exhibits31: Five forces analysis - Comparison between 2024 and 2029; Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits37: Chart on Market condition - Five forces 2024 and 2029; Exhibits38: Chart on Product - Market share 2024-2029 (%); Exhibits39: Data Table on Product - Market share 2024-2029 (%); Exhibits40: Chart on Comparison by Product; Exhibits41: Data Table on Comparison by Product; Exhibits42: Chart on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion); Exhibits43: Data Table on Monoclonal antibodies - Market size and forecast 2024-2029 ($ billion); Exhibits44: Chart on Monoclonal antibodies - Year-over-year growth 2024-2029 (%); Exhibits45: Data Table on Monoclonal antibodies - Year-over-year growth 2024-2029 (%); Exhibits46: Chart on Gene therapy - Market size and forecast 2024-2029 ($ billion); Exhibits47: Data Table on Gene therapy - Market size and forecast 2024-2029 ($ billion); Exhibits48: Chart on Gene therapy - Year-over-year growth 2024-2029 (%); Exhibits49: Data Table on Gene therapy - Year-over-year growth 2024-2029 (%); Exhibits50: Chart on Polyclonal antibodies - Market size and forecast 2024-2029 ($ billion); Exhibits51: Data Table on Polyclonal antibodies - Market size and forecast 2024-2029 ($ billion); Exhibits52: Chart on Polyclonal antibodies - Year-over-year growth 2024-2029 (%); Exhibits53: Data Table on Polyclonal antibodies - Year-over-year growth 2024-2029 (%); Exhibits54: Chart on Cell-based immunotherapy products - Market size and forecast 2024-2029 ($ billion); Exhibits55: Data Table on Cell-based immunotherapy products - Market size and forecast 2024-2029 ($ billion); Exhibits56: Chart on Cell-based immunotherapy products - Year-over-year growth 2024-2029 (%); Exhibits57: Data Table on Cell-based immunotherapy products - Year-over-year growth 2024-2029 (%); Exhibits58: Chart on Others - Market size and forecast 2024-2029 ($ billion); Exhibits59: Data Table on Others - Market size and forecast 2024-2029 ($ billion); Exhibits60: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits61: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits62: Market opportunity by Product ($ billion); Exhibits63: Data Table on Market opportunity by Product ($ billion); Exhibits64: Chart on End-user - Market share 2024-2029 (%); Exhibits65: Data Table on End-user - Market share 2024-2029 (%); Exhibits66: Chart on Comparison by End-user; Exhibits67: Data Table on Comparison by End-user; Exhibits68: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ billion); Exhibits69: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ billion); Exhibits70: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%); Exhibits71: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%); Exhibits72: Chart on CMOs and CROs - Market size and forecast 2024-2029 ($ billion); Exhibits73: Data Table on CMOs and CROs - Market size and forecast 2024-2029 ($ billion); Exhibits74: Chart on CMOs and CROs - Year-over-year growth 2024-2029 (%); Exhibits75: Data Table on CMOs and CROs - Year-over-year growth 2024-2029 (%); Exhibits76: Chart on Academic research institutes - Market size and forecast 2024-2029 ($ billion); Exhibits77: Data Table on Academic research institutes - Market size and forecast 2024-2029 ($ billion); Exhibits78: Chart on Academic research institutes - Year-over-year growth 2024-2029 (%); Exhibits79: Data Table on Academic research institutes - Year-over-year growth 2024-2029 (%); Exhibits80: Market opportunity by End-user ($ billion); Exhibits81: Data Table on Market opportunity by End-user ($ billion); Exhibits82: Chart on Diagnostic Methods - Market share 2024-2029 (%); Exhibits83: Data Table on Diagnostic Methods - Market share 2024-2029 (%); Exhibits84: Chart on Comparison by Diagnostic Methods; Exhibits85: Data Table on Comparison by Diagnostic Methods; Exhibits86: Chart on Molecular diagnostics - Market size and forecast 2024-2029 ($ billion); Exhibits87: Data Table on Molecular diagnostics - Market size and forecast 2024-2029 ($ billion); Exhibits88: Chart on Molecular diagnostics - Year-over-year growth 2024-2029 (%); Exhibits89: Data Table on Molecular diagnostics - Year-over-year growth 2024-2029 (%); Exhibits90: Chart on Immunoassays - Market size and forecast 2024-2029 ($ billion); Exhibits91: Data Table on Immunoassays - Market size and forecast 2024-2029 ($ billion); Exhibits92: Chart on Immunoassays - Year-over-year growth 2024-2029 (%); Exhibits93: Data Table on Immunoassays - Year-over-year growth 2024-2029 (%); Exhibits94: Chart on NGS - Market size and forecast 2024-2029 ($ billion); Exhibits95: Data Table on NGS - Market size and forecast 2024-2029 ($ billion); Exhibits96: Chart on NGS - Year-over-year growth 2024-2029 (%); Exhibits97: Data Table on NGS - Year-over-year growth 2024-2029 (%); Exhibits98: Market opportunity by Diagnostic Methods ($ billion); Exhibits99: Data Table on Market opportunity by Diagnostic Methods ($ billion); Exhibits100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits101: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits102: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits103: Chart on Geographic comparison; Exhibits104: Data Table on Geographic comparison; Exhibits105: Chart on North America - Market size and forecast 2024-2029 ($ billion); Exhibits106: Data Table on North America - Market size and forecast 2024-2029 ($ billion); Exhibits107: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on Europe - Market size and forecast 2024-2029 ($ billion); Exhibits110: Data Table on Europe - Market size and forecast 2024-2029 ($ billion); Exhibits111: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on Asia - Market size and forecast 2024-2029 ($ billion); Exhibits114: Data Table on Asia - Market size and forecast 2024-2029 ($ billion); Exhibits115: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Exhibits118: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Exhibits119: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on US - Market size and forecast 2024-2029 ($ billion); Exhibits122: Data Table on US - Market size and forecast 2024-2029 ($ billion); Exhibits123: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on Germany - Market size and forecast 2024-2029 ($ billion); Exhibits126: Data Table on Germany - Market size and forecast 2024-2029 ($ billion); Exhibits127: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on China - Market size and forecast 2024-2029 ($ billion); Exhibits130: Data Table on China - Market size and forecast 2024-2029 ($ billion); Exhibits131: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits133: Chart on Canada - Market size and forecast 2024-2029 ($ billion); Exhibits134: Data Table on Canada - Market size and forecast 2024-2029 ($ billion); Exhibits135: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits136: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits137: Chart on UK - Market size and forecast 2024-2029 ($ billion); Exhibits138: Data Table on UK - Market size and forecast 2024-2029 ($ billion); Exhibits139: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits140: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits141: Chart on India - Market size and forecast 2024-2029 ($ billion); Exhibits142: Data Table on India - Market size and forecast 2024-2029 ($ billion); Exhibits143: Chart on India - Year-over-year growth 2024-2029 (%); Exhibits144: Data Table on India - Year-over-year growth 2024-2029 (%); Exhibits145: Chart on France - Market size and forecast 2024-2029 ($ billion); Exhibits146: Data Table on France - Market size and forecast 2024-2029 ($ billion); Exhibits147: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits148: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits149: Chart on Japan - Market size and forecast 2024-2029 ($ billion)

Search Inside Report

Pricing

Currency Rates

Single User Online Download $2,500
Global Site License Online Download $4,000

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now